BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 3496072)

  • 1. Complement activation during hemodialysis: laboratory evaluation of hemodialyzers.
    Chenoweth DE; Henderson LW
    Artif Organs; 1987 Apr; 11(2):155-62. PubMed ID: 3496072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anaphylatoxin formation during hemodialysis: effects of different dialyzer membranes.
    Chenoweth DE; Cheung AK; Henderson LW
    Kidney Int; 1983 Dec; 24(6):764-9. PubMed ID: 6609269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compartmental distribution of complement activation products in artificial kidneys.
    Cheung AK; Chenoweth DE; Otsuka D; Henderson LW
    Kidney Int; 1986 Jul; 30(1):74-80. PubMed ID: 3489123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement activation during hemodialysis: clinical observations, proposed mechanisms, and theoretical implications.
    Chenoweth DE
    Artif Organs; 1984 Aug; 8(3):281-90. PubMed ID: 6332607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dialyzer membranes: effect of surface area and chemical modification of cellulose on complement and platelet activation.
    Mahiout A; Meinhold H; Kessel M; Schulze H; Baurmeister U
    Artif Organs; 1987 Apr; 11(2):149-54. PubMed ID: 3036050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary report on complement activating potential of polycarbonate membrane.
    Henderson LW; Chenoweth DE; Shinaberger JH; Miller J; Konstantin P
    Blood Purif; 1986; 4(1-3):74-81. PubMed ID: 3730164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anaphylatoxin formation during hemodialysis: comparison of new and re-used dialyzers.
    Chenoweth DE; Cheung AK; Ward DM; Henderson LW
    Kidney Int; 1983 Dec; 24(6):770-4. PubMed ID: 6609270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement C3 and C5 degradation products during hemodialysis treatment: study of an index of membrane bioincompatibility.
    Freyria AM; Leitienne P; Veysseyre CN; Bringuier JP; Traeger J
    Int J Artif Organs; 1988 Mar; 11(2):111-8. PubMed ID: 3259552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plate, coil, and hollow-fiber cuprammonium cellulose dialyzers: discrepancy between incidence of anaphylactic reactions and degree of complement activation.
    Daugirdas JT; Potempa LD; Dinh N; Gandhi VC; Ivanovich PT; Ing TS
    Artif Organs; 1987 Apr; 11(2):140-3. PubMed ID: 3593043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biocompatibility of different hemodialysis and plasmapheresis membranes.
    Jørstad S
    Blood Purif; 1987; 5(2-3):123-37. PubMed ID: 3497645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ex vivo biocompatibility evaluation of a new modified cellulose membrane.
    Bosch T; Schmidt B; Spencer PC; Samtleben W; Pelger M; Baurmeister U; Gurland HJ
    Artif Organs; 1987 Apr; 11(2):144-8. PubMed ID: 3496071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement activation and hypersensitivity reactions to dialysis membranes.
    Hakim RM; Breillatt J; Lazarus JM; Port FK
    N Engl J Med; 1984 Oct; 311(14):878-82. PubMed ID: 6332276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biocompatibility aspects of cellophane, cellulose acetate, polyacrylonitrile, polysulfone and polycarbonate hemodialyzers.
    Smeby LC; Widerøe TE; Balstad T; Jørstad S
    Blood Purif; 1986; 4(1-3):93-101. PubMed ID: 3730167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anaphylatoxin C5a generation and dialysis-induced leukopenia with different hemodialyzer membranes.
    Aljama P; Martín-Malo A; Castillo D; Velasco F; Torres A; Pérez R; Castro M
    Blood Purif; 1986; 4(1-3):88-92. PubMed ID: 3730166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellulose membranes--time for a change?
    Henderson LW; Chenoweth DE
    Contrib Nephrol; 1985; 44():112-26. PubMed ID: 3872769
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of complement activation by hemodialysis membranes.
    Cheung AK; Henderson LW
    Am J Nephrol; 1986; 6(2):81-91. PubMed ID: 3518458
    [No Abstract]   [Full Text] [Related]  

  • 17. Is contact activation of the coagulation system involved in the genesis of the first-use syndrome?
    Vaziri ND
    Artif Organs; 1987 Apr; 11(2):163-4. PubMed ID: 3496073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biocompatibility of hemodialysis membranes: interrelations between plasma complement and cytokine levels.
    Varela MP; Kimmel PL; Phillips TM; Mishkin GJ; Lew SQ; Bosch JP
    Blood Purif; 2001; 19(4):370-9. PubMed ID: 11574733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute changes in C3a and C5a in an anaphylactoid reaction in hemodialysis patients.
    Suzuki Y; Uchida J; Tsuji H; Kuzuhara K; Hara S; Nihei H; Ogura Y; Otsubo O; Mimura N
    Tohoku J Exp Med; 1987 May; 152(1):35-45. PubMed ID: 3497472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symptoms and activation of granulocytes and complement with two dialysis membranes.
    Ivanovich P; Chenoweth DE; Schmidt R; Klinkmann H; Boxer LA; Jacob HS; Hammerschmidt DE
    Kidney Int; 1983 Dec; 24(6):758-63. PubMed ID: 6609268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.